Two DelMar Pharmaceuticals Inc. executives recently accepted requests to join the National Brain Tumor Society's Research Roundtable, attending its premiere meeting in Washington, D.C. to consider ways research can improve clinical trials for regulatory approval. Read More »
Pfizer Inc. recently published noninferiority results from its study of Xeljanz, a twice-daily monotherapy to be used in combination with methotrexate in treating patients with moderate to severe rheumatoid arthritis. Read More »
The rights to vaccine technologies designed to combat measles and pertussis will be transferred to an India-based business following a pair of recent licensing agreements to hasten affordable protection in India, China and additional nations. Read More »
PharmaMar has obtained a trademark for its commercial formulation of PM 1183 (lurbinectedin) — developed for the treatment of ovarian and lung cancers — from European and U.S. authorities, the company announced recently from Madrid, Spain headquarters. Read More »
Hi-Tech Pharmaceuticals, a company operating in the sports nutrition industry, has acquired Top Secret Nutrition, a developer of scientifically advanced, safely sourced, high quality and effective nutritional supplements. Read More »
Population health management logistics just became easier for collective clients of two health-care administrative providers with MatrixCare’s acquisition of electronic health record (EHR) firm SigmaCare in the metropolitan New York area. Read More »
Immune Pharmaceuticals is enrolling patients in a Phase I and II clinical trial that will determine the safety and efficacy levels of Ceplene as a treatment for Chronic Myelomonocytic Leukemia. Read More »
ANI Pharmaceuticals Inc. recently made its U.S. launch of Diphenoxylate HCl and Atropine Sulfate Tablet to treat diarrhea. Read More »
Imaging3 Inc. has hired Intertek Inc. to oversee hazard analytics and U.S. Federal Drug Administration guidance protocols during the submission of the company’s Dominion VI imaging device with patented SmartScan 3D technology. Read More »
With its identity coined by the founding optometrist’s own child, RevolutionEYES’ “Little Eyes” recently opened in Carmel, Indiana, launching a pediatric eye care clinic caring for youngsters between 6 months and 13 years old. Read More »
Addressing a recently reported nationwide antacid scarcity, QuVa Pharma Inc. — specializing in critical drug shortage products — has rallied with supplies of its own pharmaceutical quality sodium bicarbonate formulation at the ready for U.S. hospital distribution. Read More »
Navidea Biopharmaceuticals Inc. recently announced that SpePharm AG has launched Lymphoseek in the Denmark, the Netherlands and the United Kingdom. Read More »
Cigna and CVS Health have launched Cigna HealthWorks, a partnership that brings Cigna benefits to CVS Pharmacy and CVS MinuteClinic retail health care centers. Read More »
Purdue Pharma's Colace product line and Senokot tablets will now come with new packaging. Read More »
MD Logistics, a third-party logistics company that works with pharmaceutical companies, will expand its Indiana operations, creating 50 new jobs in the process. Read More »
Merck has paused enrollment in two Keytruda clinical trials. Read More »
A new study published in the Journal of the American Medical Association finds that doctors are influenced by gifts and their relationships with drug company representatives. Read More »
Drug Channels, a website providing expert insights on pharmaceutical economics and the drug distribution system, recently commented on a new report from the Centers for Medicare & Medicaid Services, titled “Medicare Part D – Direct and Indirect Remuneration.” Read More »
Sandoz has introduced the authorized generic version of Alcon Research Ltd.'s Pataday, an olopatadine hydrochloride ophthalmic solution. Read More »
Omnicell Inc. announced an agreement with CompleteRX to develop a medication distribution model for the Commonwealth of Massachusetts State Office of Pharmacy Services. Read More »
Alerts Sign-up
